Articles tagged with Cancer Genomics
The collaboration aims to establish a PDX Data Commons and Coordinating Center to integrate and share PDX treatment data for research. This will enhance precision in measuring drug-response and provide a clinical trial roadmap for piloting treatments.
Researchers identified effective treatments for patients with rare cancers through genomic analysis, resulting in stabilization, shrinkage, or remission for half the patients. Precision medicine offers new hope for managing these uncommon but significant cancers.
GA4GH has struck formal collaborations with 15 international genomic data initiatives, including Genomics England and the U.S. All of Us Research Program. The goal is to create framework and standards for responsible sharing of genomic data by 2022.
A Penn study suggests that DNA 3D packaging controls which genes are available for activation, influencing cell differentiation. The researchers found that tethering DNA to the nuclear periphery with an epigenetic enzyme contributes to a cell becoming a certain type.
Julia Oh has received a $2.8 million NIH grant to explore engineered probiotic treatments for skin diseases. Her research aims to harness the skin microbiome to create new therapeutics.
A study by University of California San Diego School of Medicine researchers reveals that a simple blood test can predict which patients will respond to checkpoint inhibitor-based immunotherapies, with 45% of patients showing significant response. The findings suggest that patients with high numbers of genomic alterations in their tumo...
A multi-institutional research center has been awarded by the NIH to study ME/CFS, a debilitating disease affecting millions of Americans. The research aims to understand and develop treatments for this complex condition by analyzing patient data and microbiome changes.
A new genomic profiling study has identified genetic alterations in 96% of brain tumors in children, including genes that can be targeted with specific treatments. The study found distinct patterns of mutations between low-grade and high-grade gliomas, which could lead to more effective treatment options for these patients.
The Association for Molecular Pathology (AMP) has awarded prestigious honors to Drs. Andrew P. Feinberg, Gregory J. Tsongalis, and Alexis B. Carter for their outstanding contributions to the field of molecular diagnostics. AMP President Federico A. Monzon praised the award recipients for their decades of service to the society.
A recent study found that nearly one in four small tumours were aggressive and patients benefited from chemotherapy. Researchers identified a 70-gene signature to detect aggressive tumours.
Researchers analyzed 9,000 proteins in bowel cancer cells to identify networks driving the disease. The study found that proteins can predict drug responses and suggests personalized medicine for patients.
A University of Colorado Cancer Center paper describes a mechanism linking viral infection and cancer caused by APOBEC3 enzymes, which are part of the immune system's response to viruses. The research suggests that targeting these enzymes could prevent or treat certain types of cancer.
A study has identified a genetic signature linked to defects in the DNA damage repair-genes BRCA1 and BRCA2 in breast cancer. The researchers found that this signature is not exclusive to BRCA mutations but also indicates other ways of deactivating the DNA repair mechanism, offering new insights into breast cancer treatment decisions.
Ouyang aims to decipher RNA structure's role in post-transcriptional regulation, providing insights into health and diseases. He plans to develop a precise genomic blueprint for clinical diagnoses and prognoses, as well as new therapies for cancer and other diseases.
The Human Pathology Atlas analyzes human genes in all major cancers, revealing patterns that influence patient survival. The atlas provides a powerful tool for personalized medicine, with potential applications in lung and colorectal cancer.
A new study found that sharing personalized melanoma genomic risk information with relatives and friends can lead to increased discussions about skin cancer prevention. The study suggests that this process could encourage healthy behavior change within families.
Researchers discovered dozens of new genes involved in resistance to immunotherapy treatments for cancer patients. The study used a novel CRISPR technique to examine genetic mutations in cancer cells and their interactions with the immune system.
The Treehouse Childhood Cancer Initiative has made a comprehensive tumor database available for researchers to use in the fight against childhood cancer. The database contains RNA-Seq gene expression data and demographic information, covering over 11,000 cases of pediatric cancer.
Researchers found that black women are more likely to have aggressive breast cancer subtypes, such as basal-like and HER2-enriched tumors. The study suggests that genomic testing could help explain the disparity in survival rates between black and white women with breast cancer.
Researchers found that age is the most strongly associated breast cancer risk factor with normal breast DNA methylation differences. The study characterized molecular differences in healthy tissues that may contribute to cancer risk, providing insight into how epigenetic dysregulation contributes to breast cancer.
Scientists at the University of Texas at Austin have developed a technique that can spot editing mistakes made by CRISPR, allowing for more precise gene therapies. The method involves rapidly testing a CRISPR molecule across a person's entire genome to foresee potential interactions.
Researchers at the University of Oxford have discovered that cancer cells manipulate a natural cell process called nonsense-mediated decay (NMD) to promote their survival. By understanding how NMD affects different types of cancer, scientists may be able to develop new treatments and therapies to control tumour growth.
A study by the University of Edinburgh reveals that dynamic DNA properties can ward off gene damage and promote genome organization. The research highlights the importance of scaffold attachment factor A in forming a protective chromatin mesh that allows for flexible and responsive cell signals.
A new technique developed by UNC School of Medicine scientists has mapped DNA damage caused by cigarette smoking at high resolution across the genome. The study provides a genome-wide map of the damage caused by benzo[α]pyrene, a chemical that accounts for about 30 percent of cancer deaths in the United States.
Raja Mazumder is developing databases BioMuta and BioXpress to standardize cancer genomics data, making it easier for researchers to integrate and compare data across various platforms. The project aims to connect cancer genomics mutation and expression data within an evolutionary context.
A recent study by Virginia Commonwealth University researchers has challenged traditional views of human papilloma virus (HPV) in HPV-related head and neck cancers. The study found that most HPV-related head and neck cancers have episomal HPV, not integrated HPV, which is associated with better treatment outcomes.
The Melanoma Research Alliance awarded Dr. Neville Sanjana a grant to use CRISPR technology to identify genetic mutations causing immunotherapy resistance in melanoma. The goal is to create a list of actionable mutations for patients enrolled in melanoma immunotherapy trials.
Researchers link cancer's high mutation rate to an ancient stress response mechanism used by single-celled organisms. The discovery sheds new light on the evolution of cancer genes and may lead to novel therapeutic approaches.
Researchers at Duke-NUS Medical School and Genome Institute of Singapore have identified altered promoters in gastric cancer that change gene expression profiles, enabling tumors to evade the immune system. The study's findings may lead to new approaches for cancer immunotherapy treatment.
Researchers analyzed DNA methylation levels in 1,900 participants to identify 58 CpGs linked to mortality. These epigenetic marks show stronger correlations with survival than previously studied genetic alterations.
Researchers analyzed 57 tissue samples from women with uterine carcinosarcoma and found that the tumors share some genetic traits but also exhibit great diversity. This diversity makes it challenging to find effective treatments for the cancer, which has a low survival rate.
Researchers have identified a new class of reader proteins linked to cancer, including leukemia. Disrupting these proteins may lead to effective combination therapies.
A new framework uses math to understand how genetic information and cell interactions give rise to tissue function, potentially aiding in understanding diseases like cancer. Researchers aim to apply this approach to real-world genome and cell biology experiments to inform future work on cancer and cell reprogramming.
Researchers at Cincinnati Children's Hospital Medical Center successfully treated patients with deadly, treatment-resistant blood cancers using gene-guided therapy. The targeted approach identified specific genes fueling the diseases and prescribed molecular drugs to put them into remission.
The APOLLO network partners with the Paulovich Laboratory to develop a panel of tests to measure key proteins in tumors, enabling targeted cancer treatments. The effort aims to improve precision-based medicine by combining genomic and proteomic approaches.
Researchers at Jackson Laboratory have identified a newly discovered telomere maintenance mechanism that enables cancer cells to survive and thrive. The study found that most cancer cells reactivate telomerase through TERT transcription, but the exact mechanisms behind this process remained unclear until now.
The CIViC knowledgebase is an open-access resource that allows anyone to contribute information on cancer mutations. Experts in the field curate and moderate submissions, providing a valuable resource for clinicians to identify important mutations and connect genetic errors with targeted drugs.
A new technique called MATQ-seq increases the accuracy of detecting gene expression in single cells to 90%, allowing scientists to study how cancerous tumors begin and potentially uncover better treatments, diagnosis, and prevention strategies.
Researchers found 33 places in breast cancer genomes where tandem duplications were most often found, leading to further cancerous changes. These 'hotspots' may create new driver mutations, making tumours more aggressive and potentially responsive to different treatments.
Researchers identified novel genomic characteristics of cervical cancer, including cell signaling pathways and human papillomavirus (HPV) infection. The study also found amplification of genes involved in immune responses and potential therapeutic targets.
A new study found that high-aneuploidy tumors have increased expression of genes involved in DNA replication and cell cycle, but decreased expression of genes characteristic of immune cells. This suggests that jumbled chromosomes in tumors may limit the effectiveness of immunotherapy treatments.
Researchers discovered cancer-driving gene mutations in uterine lavage fluid of women with and without endometrial cancer. The study's findings suggest that these pre-cancerous mutations can be detected using advanced genomic technologies, potentially leading to earlier diagnosis and improved treatment outcomes.
Three researchers were awarded the Brupbacher Cancer Research Prize for their work on epigenetics, which regulates gene activity and is linked to cancer development. The team's findings suggest that epigenetic changes can trigger abnormal gene inactivation in tumor cells.
A research team at the University of Basel has discovered a cancer type-specific 'signature' based on ribosomal protein expression. This signature may serve as a prognostic marker for cancer and point towards new therapeutic opportunities, with a strong relationship found between the signature in breast cancer and relapse-free survival.
Researchers capture elusive DNA reaction intermediates in living cells, discovering mechanisms underlying genome instability and a new role for an E. coli protein related to human cancer proteins. This breakthrough could lead to the development of new drugs that prevent cancer by neutralizing these key pieces of genetic code.
The National Cancer Institute has granted $2.5 million to Van Andel Research Institute and Cedars-Sinai to develop better diagnostic and treatment strategies for cancer. The project aims to uncover the underpinnings of cancer by analyzing epigenetic data from thousands of samples.
Researchers develop universal assay to detect cisplatin cross-linking sites in the genome. They found that mitochondrial DNA is a major target of cisplatin's action, while nuclear DNA is less affected.
Researchers from Colorado State University discovered that a cancer cell's shape may offer similar clues to predict how dangerous it is and guide treatment strategies. By analyzing cell shape using Zernike moments, the team was able to identify patterns that distinguish invasive osteosarcoma cell lines.
Scientists have long assumed chimeric RNA indicates cancer, but new research reveals these fusions can also be a normal part of human genetics. Researchers are working to develop more accurate biomarkers and therapeutic targets by understanding the complexities of normal genetic programming.
Researchers found two genomic regions changing in response to devil facial tumor disease, which has killed an estimated 80% of Tasmanian devils. The study suggests genetic resistance could help the species avoid extinction, with potential implications for cancer and immune function research.
Two key protein complexes, condensin and cohesin, play critical roles in organizing chromosomes during cell division. A recent study sheds new light on the specific functions of these proteins, which can help pinpoint the origins of genetic diseases like cancer.
A new measurement standard, developed by NIST, has been used to evaluate the performance of next-generation DNA-sequencing technologies for evaluating gene variations associated with an increased risk of breast cancer. The HER2 Standard Reference Material demonstrates its value in increasing confidence in reporting HER2 amplification f...
Researchers at Stanford Medicine developed a machine-learning approach that accurately differentiates between two types of lung cancers and predicts patient survival times better than human pathologists. The method assesses critical disease-related features, including cell size, shape, and texture, to improve patient outcomes.
Researchers found that treating human breast cancer tumors with estrogen-deprivation therapy changes the spectrum of mutations in the tumor population. This suggests using this information to improve cancer treatment. The study also discovered 'collision tumors' - separate tumors of different origin growing closely together, undiagnose...
The National Institutes of Health (NIH) has awarded $28.3 million to The Jackson Laboratory over five years to fund phase 2 of the Knockout Mouse Production and Phenotyping Project (KOMP2). This project aims to create targeted knockout mutations for every gene in the mouse genome, providing valuable clues to their function.
A Yale research team designed a system to modify multiple genes in the genome simultaneously, reducing unintended effects. The gene-editing 'toolbox' provides a user-friendly solution for studying cancer and other diseases.
A molecule believed to indicate good cancer prognosis has been shown to cause genomic instability and promote tumor growth. The study, published in Nature Cell Biology, suggests that targeting p21 could lead to new cancer treatments.
Whole-genome gene expression and methylation data offer more predictive power than commonly-used clinical information in breast cancer survival predictions. Combining these data with clinical information improves predictions, suggesting a promising genomic approach for future clinic applications.
Researchers have discovered a positive correlation between gene mutation 'hotspots' and better breast cancer outcomes, including lower tumor invasiveness and longer patient survival. These findings could inform prognosis and help identify patients who would best respond to immunotherapy and other treatments.
The Jackson Laboratory's Gene Expression Database (GXD) will receive $10.5 million in funding over five years to support data curation and integration, infrastructure expansion, and enhanced tools.